Drug Shortage Report for TARO-ZOLEDRONIC ACID CONCENTRATE

Last updated on 2022-11-24 History
Report ID 175655
Drug Identification Number 02415186
Brand name TARO-ZOLEDRONIC ACID CONCENTRATE
Common or Proper name ZOLEDRONIC
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) ZOLEDRONIC ACID
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ML
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-19
Estimated end date 2023-02-10
Actual end date
Shortage status Actual shortage
Updated date 2022-11-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-11-24 French Compare
v1 2022-11-24 English Compare

Showing 1 to 2 of 2